# RWD102 ASSESSING THE COST-UTILITY OF LECANEMAB FOR EARLY ALZHEIMER'S DISEASE TREATMENT AND THE NEED FOR REAL-WORLD EVIDENCE: A SINGAPORE PERSPECTIVE

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rwd102-assessing-the-cost-utility-of-lecanemab-for-early-alzheimer-s-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Malvin Kang,Jia Hao Wong,A Gras,T. Kanzaki |
| Citations | 0 |
| DOI | 10.1016/j.vhri.2025.101331 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.vhri.2025.101331 |
| OpenAlex ID | https://openalex.org/W4415730352 |
| Type | conference-abstract |
| Year | 2025 |

## Paper authors

- [Malvin Kang](https://scholariq.org/researchers/malvin-kang/)

## Paper journal

- [Value in Health Regional Issues](https://scholariq.org/journals/value-in-health-regional-issues/)

## Paper primary topic

- [Alcoholism and Thiamine Deficiency](https://scholariq.org/topics/alcoholism-and-thiamine-deficiency/)

## Paper topics

- [Alcoholism and Thiamine Deficiency](https://scholariq.org/topics/alcoholism-and-thiamine-deficiency/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.